Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.8 USD | -0.51% | -0.38% | +4.76% |
May. 13 | Balchem Insider Sold Shares Worth $297,935, According to a Recent SEC Filing | MT |
May. 06 | HC Wainwright Adjusts Balchem Price Target to $170 From $167, Maintains Buy Rating | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 40.34 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.76% | 5.05B | B- | ||
+17.80% | 66.73B | A- | ||
+2.92% | 49.79B | A- | ||
+19.98% | 42.5B | B+ | ||
+23.11% | 26.45B | A- | ||
+12.04% | 19.66B | C+ | ||
+1.27% | 17.18B | B+ | ||
-22.98% | 15.82B | A- | ||
+2.77% | 15.56B | B+ | ||
-9.25% | 15.41B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BCPC Stock
- Ratings Balchem Corporation